Mardi Dier - 10 Mar 2025 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Signature
/s/ Mardi Dier
Issuer symbol
MDGL
Transactions as of
10 Mar 2025
Net transactions value
-$83,344
Form type
4
Filing time
12 Mar 2025, 16:32:09 UTC
Previous filing
07 Mar 2025
Next filing
13 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Sale $83,344 -258 -2.4% $323.04 10,440 10 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024.